Andere talen Teva Pharmaceutical Industries Limited London S.E.

Aandelen

0LER

US8816242098

Beurs gesloten - London S.E. Andere beurzen 17:30:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
16,2 ^USD	-4,42%		-0,64%	+55,25%

17/05	Teva Pharmaceutical Industries Insider verkocht aandelen ter waarde van $ 470.794, volgens een recent SEC-document	MT
15/05	Teva Pharmaceutical Industries Insider verkocht aandelen ter waarde van $254.807, volgens een recente SEC filing	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	17/05
New EVP, Teva Global Operations appointed	16/05
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	15/05
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations	15/05
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	15/05
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia	09/05
En Direct des Marchés : Sabadell, TotalEnergies, Airbnb, ARM, Medincell, Nexi...	09/05
Teva Pharmaceutical Industries : Immediate Report	08/05
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	08/05
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	08/05
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05
Sector Update: Health Care	08/05
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	08/05
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B	08/05
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48	08/05
Teva Pharm Q1 profit falls short of estimates, revenue gains	08/05
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook	08/05
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Teva Pharmaceutical Industries Limited Reports Impairment of Long-Lived Assets for the Three Months Ended March 31, 2024	08/05
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024	08/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Teva CEO over tweede kwartaal, mogelijke schikking met DOJ

02 augustus 2023 om 21:19 uur